Upcoming Events
Startup Demo Day
Wednesday, October 18, 2023 (5:00 PM - 8:00 PM) (EDT)
Description
Marking the half-way point of the Medtech IGNITE 2023 Accelerator Program, this event will feature the current class of cohort participants pitching their companies. Join us to hear from the hottest start-ups in medtech and enjoy tours from Cambridge Consultants, including an open house of their Digital Operating Room.
The 2023 IGNITE Cohort includes:
Aim Medical Robotics is working to bring high levels of precision, automation, and efficiency to the complex environment of neurosurgery. Aim is developing a portable MRI compatible surgical robot for use in the MRI suite and the operating room.
Brainbot has developed the first gamified concussion recovery app that facilitates rehabilitation through health optimization and self-management at home.
Craniosense is changing the trajectory of care for TBI patients by enabling all healthcare providers to identify those at risk of intracranial hypertension, anytime, anywhere.
Deeplook Medical partners with innovators in medical imaging with the latest in image display technology, innovative AI platforms and cloud-enabled image viewers. FDA-cleared DL Precise™ automates lesion segmentation and measurement with unprecedented precision in multiple imaging modalities (ultrasound, mammography, CT, MRI) – all with a single click.
GuidewireRx has developed VascularAssistTM, an artificial intelligence platform for radiologists and hospitals to assist in the timely diagnosis of peripheral vascular disease to prevent amputation.
NED Medical is seeking to transform oncology embolization therapy from a palliative to a curative-intent treatment with the mission of improving outcomes for patients with unresectable tumors.
PMD Solutions is the maker of RespiraSense. RespiraSense transforms the measurement of a patient’s respiratory rate with continuous, innovative technology monitoring – improving the measurement and identification of deterioration, in real-time to help save lives.
RhinUS is a medical device developed to treat the root cause of chronic rhinosinusitis (CRS), a condition affecting more than 30M Americans. Conceived by two engineers at Harvard Medical School, RhinUS combines the ease of in-office treatments with lasting symptom relief for CRS patients.
AGENDA
5:00 - 5:30 PM - Registration & Networking
5:30 - 6:00 PM - Optional Tours of the Digital Operating Room
6:00 - 7:30 PM - Program
7:30 - 8:00 PM - Networking
2 Drydock Avenue Boston Suite 1210
Boston, MA 02110 United States